BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

INDGN vs VIMTALABS: Stock Comparison

INDEGENE vs VIMTA LABSUpdated 20 Nov 26, 4:08 PM ISTNSE & company filings

INDEGENE is the larger company by market capitalisation. INDEGENE shows faster revenue growth and lower leverage, while VIMTA LABS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDGN leads 3; VIMTALABS leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDGNVIMTALABS

Valuation lens

What price are you paying?

Market CapContext only
₹15,807 Cr
₹2,083 Cr
P/E RatioVIMTALABS has the lower reading
38.43x
0x ✓
P/B RatioVIMTALABS has the lower reading
4.71x
0x ✓
EPSVIMTALABS has the higher reading
₹4.66
₹4.84 ✓
Book ValueContext only
₹130.25
₹102.84
Dividend YieldVIMTALABS has the higher reading
0.34%
0.43% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
INDGN is the larger company
₹15,807 Cr vs ₹2,083 Cr
P/E Ratio
VIMTALABS has a lower P/E
0x vs 38.43x
P/B Ratio
VIMTALABS has a lower P/B
0x vs 4.71x
EPS
VIMTALABS has higher earnings per share
₹4.84 vs ₹4.66
Dividend Yield
VIMTALABS has a higher dividend yield
0.43% vs 0.34%
Revenue Growth (TTM YoY)
INDGN has faster revenue growth
32.8% vs 16.5%
EPS Growth (TTM YoY)
VIMTALABS has faster EPS growth
14.3% vs -32.3%
Qtr Sales Growth
INDGN has stronger quarterly sales growth
5.57% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDGNVIMTALABS
SectorHealthcareHealthcare
IndustryHealthcare Research Analytics & TechnologyHealthcare Research Analytics & Technology

Price

MetricINDGNVIMTALABS
Live Price₹657.65₹467.65
Day Change1.9%-0.91%
Volume3.21 L49,984
52-Week High₹677₹675
52-Week Low₹414₹376.05
Distance from 52W High-2.86%-30.72%

Valuation

MetricINDGNVIMTALABS
Market Cap₹15,807 Cr₹2,083 Cr
P/E Ratio38.43x0x
P/B Ratio4.71x0x
EPS₹4.66₹4.84
Book Value₹130.25₹102.84
Dividend Yield0.34%0.43%

Growth

MetricINDGNVIMTALABS
Revenue Growth (TTM YoY)32.8%16.5%
EPS Growth (TTM YoY)-32.3%14.3%
Qtr Sales Growth5.57%0%
Qtr Profit Growth-3.36%0%

Profitability & Leverage

MetricINDGNVIMTALABS
ROE10.19%16.97%
ROCE10.75%17.48%
Net Margin12.03%19.03%
Operating Margin23.77%25.81%
Debt to Equity0x0.01x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricINDGNVIMTALABS
Promoter Holding—35.64%▼ 0.03 pp
FII Holding12.4%▲ 2.49 pp5.07%▲ 0.65 pp
DII Holding15.82%▲ 7.08 pp0.48%▲ 0.11 pp
Public Holding71.77%▼ 9.57 pp58.8%▼ 0.75 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDEGENE and VIMTA LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.